Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Patients Facing Blindness to Test Therapy with Stem Cells

January 6, 2011 7:36 pm | by Massachusetts Institute of Technology | News | Comments

Replacing certain cells in the retina could slow visual impairment for people with macular degeneration.

Conceptus says 4Q sales fell short of estimates

January 6, 2011 1:45 pm | by The Associated Press | News | Comments

Conceptus Inc. said Thursday that its fourth-quarter revenue was less than expected because of weaker demand for its Essure birth control procedure.The company said its fourth quarter sales will be between $36.3 million and $36.6 million. That's a decrease of 1 to 2 percent from a year ago....

ImmuCor 2Q profit rises as expenses decrease

January 6, 2011 12:45 pm | by The Associated Press | News | Comments

Blood-testing equipment maker ImmuCor Inc. said Thursday its profit grew 7 percent in the fiscal second quarter as it reduced its expenses to make up for a decrease in revenue.ImmuCor said its earned $21.1 million, or 30 cents per share, in the three months ended Nov. 30. That was up from $19.7...

Advertisement

ThermoGenesis registers to sell $20M in securities

January 6, 2011 12:45 pm | by The Associated Press | News | Comments

Biotechnology company ThermoGenesis Corp. said Thursday that it filed a shelf registration statement to sell up to $20 million in common stock and warrants.The registration statement has not yet been declared effective by the Securities and Exchange Commission.The company, based in Rancho...

Use Your Web Site to Connect with Patients, Referring Docs

January 6, 2011 11:35 am | by Diagnostic Imaging | News | Comments

Physicians are not always the first adopters of new technology, and the use of Web content is no exception. Of course, most of our business has no direct correlation with information from the Web, but that does not mean that having a Web site is not a great addition to the practice.

TOPICS:

Metronidazole Tablets, 250mg: Recall - Underweight Tablets

January 6, 2011 11:31 am | by U.S. Food & Drug Administration | News | Comments

Underweight tablets may not contain the full amount of active ingredient within a single tablet. A consumer may not receive the prescribed dose, which may cause the infection the drug was intended to treat to worsen or recur, which could be life-threatening when treating severe infections.

TOPICS:

Triad Alcohol Prep Pads, Alcohol Swabs, and Alcohol Swabsticks: Recall Due to Potential Microbial Contamination(2)

January 6, 2011 11:31 am | by U.S. Food & Drug Administration | News | Comments

Use of contaminated Alcohol Prep Pads, Alcohol Swabs or Alcohol Swabsticks could lead to life-threatening infections, especially in at risk populations, including immune suppressed and surgical patients.

TOPICS:

Triad Alcohol Prep Pads, Alcohol Swabs, and Alcohol Swabsticks: Recall Due to Potential Microbial Contamination

January 6, 2011 11:30 am | News | Comments

Use of contaminated Alcohol Prep Pads, Alcohol Swabs or Alcohol Swabsticks could lead to life-threatening infections, especially in at risk populations, including immune suppressed and surgical patients.

Advertisement

Canadian General Investments: Investment Update-Unaudited

January 6, 2011 10:45 am | by The Associated Press | News | Comments

http://www.mmainvestments.com/ () —Canadian General Investments, Limited (CGI) (TSX: CGI)(TSX: CGI.PR.B)(TSX: CGI.PR.C)(LSE: CGI) reports on an unaudited basis that its net asset value per share (NAV) at December 31, 2010 was $24.05, resulting in a one-year NAV return, with dividends...

IBM and the Premier Healthcare Alliance to Integrate Nation's Healthcare Data to Gain Insight, Measure Performance and Improve Population Health

January 6, 2011 10:34 am | by IBM | News | Comments

IBM and the Premier healthcare alliance today announced plans to integrate health information from across hospitals and other healthcare sites. More than 2,400 hospitals and thousands of other healthcare sites will benefit from this model to help improve clinical outcomes, reduce waste...

Nonin Medical Announces Microsoft® HealthVaultâ„¢ Certification of Worldâ??s First Continuaâ„¢-Certified, Bluetooth® Wireless Fingertip Pulse Oximeter at CES 2011

January 6, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

MINNEAPOLIS, Jan. 6, 2011 /- Nonin Medical, Inc., the inventor of fingertip pulse oximetry and a leader in noninvasive physiological monitoring, today announced that the Onyx® II Model 9560 Continua™-Certified, Bluetooth® wireless fingertip pulse oximeter has received...

TOPICS:

Century Park Capital Partners Announces the Recapitalization of Cirtec Medical Systems, LLC(2)

January 6, 2011 7:37 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, Jan. 6, 2011 /- Century Park Capital Partners is pleased to announce that it led the recapitalization of Cirtec Medical Systems, LLC ("Cirtec") along with Charter Oak Equity and the company's founders. Cirtec is a leading provider of client focused, comprehensive medical...

TOPICS:

Saints Medical Center and ZOLL Medical Corporation Enter Collaborative Agreement

January 6, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

LOWELL, Mass., Jan. 6, 2011 /- Saints Medical Center, a leading non-profit healthcare facility in the Greater Lowell area, is pleased to announce it has entered into a multi-faceted agreement with ZOLL Medical Corporation (Nasdaq: ZOLL ) of Chelmsford, Mass., a leader in comprehensive...

TOPICS:

SV Life Sciences Promotes 30-Year MedTech Veteran Paul LaViolette to Partner

January 6, 2011 7:36 am | by Bio-Medicine.Org | News | Comments

BOSTON, SAN FRANCISCO and LONDON, Jan. 6, 2011 /- SV Life Sciences ("SVLS") today announced the promotion of Paul LaViolette to Partner. Mr. LaViolette joined SVLS in early 2009 as Venture Partner. "Since joining SVLS, Paul has successfully applied his tremendous experience with...

TOPICS:

Isis Pharmaceuticals to Present at the 29th Annual J.P. Morgan Healthcare Conference

January 6, 2011 7:35 am | by Bio-Medicine.Org | News | Comments

CARLSBAD, Calif., Jan. 6, 2011 /- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader in antisense therapeutics, today announced that management will present a company overview at J.P. Morgan's 29th Annual Healthcare Conference on Thursday, January 13, 2011 at 8:00 a.m. PST at the...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading